France · Delayed Price · Currency is EUR L'Oréal Earnings Call Transcripts
Fiscal Year 2026
-
Adjusted like-for-like sales grew 6.7% in Q1 2026, outpacing the global beauty market. Strong innovation, e-commerce, and premiumization drove gains across all regions, with China and SAPMENA outperforming. Inflation and Middle East risks are being closely monitored.
-
Strong financial results in 2025 were driven by innovation, strategic acquisitions, and robust growth in the U.S., China, and emerging markets. Investments in AI, e-commerce, and new categories like longevity and aesthetics position the company for continued outperformance and market leadership.
Fiscal Year 2025
-
2025 saw 4% like-for-like growth, record margins, and strong cash flow, with e-commerce surpassing 30% of sales and emerging markets driving 40% of growth. All divisions grew, led by Professional Products, and innovation is set to accelerate further in 2026, despite ongoing FX and tariff headwinds.
-
With a 16% U.S. market share and leadership across all beauty categories, the group leverages a diverse brand portfolio, robust innovation, and advanced digital capabilities to drive growth. Strategic acquisitions, omnichannel expansion, and AI integration position it for continued market share gains.
-
The discussion highlighted accelerating beauty market growth, driven by digital innovation, e-commerce, and premiumization, with strong performance in the U.S., China, and emerging markets. Continued investment in R&I, M&A, and a robust channel strategy underpin long-term resilience and leadership.
-
Luxury beauty leads luxury personal goods with strong growth, driven by innovation, a balanced brand portfolio, and global expansion. Outperformance continues in all regions and categories, with recent acquisitions and digital upgrades fueling future growth.
-
Sales growth accelerated to +4.9% in Q3, led by innovation, strong fragrance and makeup launches, and robust e-commerce. The €4B Kering Beauty acquisition strengthens luxury leadership, while market share gains were seen in China, the U.S., and Europe.
-
Market leadership is reinforced by strong brand portfolio, innovation, and global reach. Recent growth is driven by e-commerce, new product launches, and resilience across regions and categories. Strategic M&A and partnerships, along with an omnichannel approach, support continued outperformance.
-
Solid first-half results with 3% like-for-like growth, record 21.1% operating margin, and strong cash flow. Emerging markets and e-commerce drove growth, while tariffs and FX posed headwinds. New launches and acquisitions are set to accelerate H2 performance.
-
L'Oréal presented at the Deutsche Bank Global Consumer Conference, emphasizing its resilience, global reach, and strong market outperformance. Strategic transformation, digital innovation, and a focus on new consumer segments and geographies underpin its growth outlook, with continued strength expected in fragrances and dermatological beauty.
-
Organic sales grew 3.5% in Q1 2025, led by fragrance and hair care, with Europe as the top contributor. U.S. growth lagged, China outperformed a flat market, and online sales accelerated. Full-year growth is expected at the lower end of 4%-4.5% amid ongoing volatility.
-
Delivered strong 2024 results with market outperformance, margin expansion, and reduced China exposure. Focused on innovation, AI, and new consumer segments, with major growth opportunities in the U.S. and emerging markets. Confident outlook for 2025 and beyond.
Fiscal Year 2024
-
Record 2024 results with sales up 5.6% to €43.5B, gross margin at 74.2%, and operating margin at 20%. Strong growth in Dermatological Beauty and Professional Products offset softness in China and travel retail. 2025 outlook targets market outperformance and margin expansion.
-
Achieved 6% like-for-like sales growth in the first nine months of 2024, outperforming the global beauty market despite headwinds in China and travel retail. Fragrance and haircare segments led growth, while a robust innovation pipeline and Beauty Stimulus Plan are set to drive 2025 performance.
-
A 10% minority stake in Galderma enables strategic entry into the injectable aesthetics market, leveraging scientific synergies while maintaining independent operations. The partnership is structured to avoid competition concerns and is seen as a long-term learning and growth opportunity.
-
Strong first-half results with 7.3% like-for-like sales growth and 8.8% net profit increase, driven by balanced volume and value gains across all divisions. Robust growth in Europe, North America, and emerging markets offset North Asia weakness, with continued margin expansion and confidence in long-term outperformance.